Karpinkaia V Yu, Tumova M A, Yanushko M G, Sosin D N, Maksimova A A, Ivanov M V
N. Bekhtereva Institute of the Human Brain Russian Academy of Sciences, St. Petersburg, Russia.
Bekhterev National Research Medical Centre for Psychiatry and Neurology, St. Petersburg, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(8):61-66. doi: 10.17116/jnevro202112108161.
To investigate whether visual processing abnormalities are the result of visual dysfunction involving cognitive impairment or independent abnormalities and to identify the relationship of visual impairments with cognitive functions and severity of psychopathological symptoms.
We compared results of visual size perception and actions on objects (motor assessment) in patients with schizophrenia (=37), including patients with non-resistant schizophrenia (=19) and healthy individuals (=20). Cognitive impairments were assessed with BACS. Severity of schizophrenia symptoms was assessed with PANSS.
The error in the visual size perception test was smaller in healthy controls compared with non-resistant patients (<0.03). There are no significant differences between non-resistant patients and other groups. Also, there are no significant differences in motor assessment between healthy controls and patients with schizophrenia. In the visual size perception test, the amount of error correlates with cognitive impairments (= -0.84, <0.001), and the severity of psychotic symptoms on PANSS (=0.55, <0.05).
Changes in visual threshold in patients with schizophrenia are correlated with cognitive dysfunction and reflect dysfunction in the parvocellular system.
研究视觉加工异常是涉及认知障碍的视觉功能障碍的结果还是独立的异常,并确定视觉障碍与认知功能及精神病理症状严重程度之间的关系。
我们比较了精神分裂症患者(=37例,包括非耐药性精神分裂症患者=19例)和健康个体(=20例)的视觉大小感知结果及对物体的动作(运动评估)。用BACS评估认知障碍。用PANSS评估精神分裂症症状的严重程度。
与非耐药性患者相比,健康对照者在视觉大小感知测试中的误差较小(<0.03)。非耐药性患者与其他组之间无显著差异。此外,健康对照者与精神分裂症患者在运动评估方面也无显著差异。在视觉大小感知测试中,误差量与认知障碍相关(=-0.84,<0.001),与PANSS上的精神病症状严重程度相关(=0.55,<0.05)。
精神分裂症患者视觉阈值的变化与认知功能障碍相关,反映了小细胞系统的功能障碍。